F. Kevin Dye
Finanzdirektor/CFO bei Advanced Catheter Therapies, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Paul J. Fitzpatrick | M | - |
Advanced Catheter Therapies, Inc.
 Advanced Catheter Therapies, Inc. Medical SpecialtiesHealth Technology Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN. | 16 Jahre |
| Dirk V. Hoyns | M | - |
Advanced Catheter Therapies, Inc.
Advanced Catheter Therapies, Inc. Medical SpecialtiesHealth Technology Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN. | 16 Jahre |
| David A. Belitz | M | - |
Advanced Catheter Therapies, Inc.
Advanced Catheter Therapies, Inc. Medical SpecialtiesHealth Technology Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN. | - |
| C. Rex Teeslink | M | - |
Advanced Catheter Therapies, Inc.
Advanced Catheter Therapies, Inc. Medical SpecialtiesHealth Technology Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN. | 16 Jahre |
| J. Scott Adams | M | - |
Advanced Catheter Therapies, Inc.
Advanced Catheter Therapies, Inc. Medical SpecialtiesHealth Technology Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN. | - |
| Frank Bunch | M | - |
Advanced Catheter Therapies, Inc.
Advanced Catheter Therapies, Inc. Medical SpecialtiesHealth Technology Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN. | - |
| Henry Krebs | M | - |
Advanced Catheter Therapies, Inc.
Advanced Catheter Therapies, Inc. Medical SpecialtiesHealth Technology Advanced Catheter Therapies, Inc. operates as an early stage research and development medical device company. It develops a catheter technologies targeting vascular disease including thrombosis, inflammation, occlusions and restenosis. The company was founded by C. Rex Teeslink, Paul J. Fitzpatrick, and Dirk V. Hoyns in 2008 and is headquartered in Chattanooga, TN. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 7 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- F. Kevin Dye
- Persönliches Netzwerk
